Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Harbor Health Care ETF N.MEDI


Primary Symbol: MEDI

The Fund seeks long-term growth of capital. The Fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization. Under normal market conditions, the Fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry (health care companies). Health care companies may include, for example, manufacturers of health care equipment and supplies, health care services providers, pharmaceutical companies, biotechnology and life sciences companies, and suppliers of technologies for use by health care companies. The Fund may invest in issuers of all market capitalizations, including larger, established issuers and newer companies with little or no current revenues.


ARCA:MEDI - Post by User

Post by StockHawk1on Dec 24, 2021 6:09pm
192 Views
Post# 34261800

solid Q122 financials for $MEDI

solid Q122 financials for $MEDI

If those looking to invest in the ketamine therapy sector while it is still a budding industry I would recommend looking into KetamineOne ( $MEDI $KONEF ).


$MEDI recently released their financials for Q122 (which ended October 31st, 2021 for the company) and they were really promising. 


Their total assets equated to $19.08M and the revenue made was $1. 99M which in the same quarter last year was $nil.


Similarly, gross profit in Q121 was $nil but it grew to $594k Q122. 


If you're into investing in novel medication/drugs/treatment and/or psychedelics definitely check out $MEDI's full financials here: https://ca.finance.yahoo.com/news/ketamine-one-reports-strong-1q22-080000368.html


$MEDI @ $0.29, MC $29.971M

 
<< Previous
Bullboard Posts
Next >>